Jiangsu Dongxing Smart Medical Technology Co., Ltd.
Announcement of Resolutions of the 17th Meeting of the Fourth Board of Directors
The Company and all members of the Board of Directors guarantee the content of the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
I. Convening of the Board Meeting
The 17th Meeting of the Fourth Board of Directors of Jiangsu Dongxing Smart Medical Technology Co., Ltd. (hereinafter referred to as the "Company") was held in the Company's meeting room on June 12, 2026, at 8:30 AM in a on-site format. All directors unanimously agreed to waive the notice period requirement, and the attending directors were aware of the necessary information related to the matters to be discussed. The meeting notice was sent by manual delivery, email, and other methods on June 12, 2026. A total of 8 directors were eligible to attend, and 8 directors actually attended. The meeting was convened and presided over by Chairman Wan Shiping, and senior management personnel of the Company were present as non-voting attendees. The convening, holding, and voting procedures of this meeting comply with the relevant laws and regulations such as the "Company Law of the People's Republic of China" (hereinafter referred to as the "Company Law") and the Company's Articles of Association.
II. Deliberation of Board Meeting Matters
After careful deliberation by all directors, the following resolutions were formed:
(I) Deliberation and Approval of the "Proposal on Adjusting the Company's Major Asset Restructuring Transaction Plan"
The Company intends to acquire 90% of the equity of Wuhan Yijia Bao Medical Materials Co., Ltd. (hereinafter referred to as the "Transaction") by paying cash.
After negotiation with the transaction counterparty, the parties to the transaction have agreed to adjust the "Performance Commitment and Compensation" clauses in the transaction plan, adding 2028 as the performance commitment period for the transaction counterparty, and correspondingly setting up compensation arrangements for failure to meet the committed performance. Based on this, it is proposed to make partial adjustments to the "Proposal on Adjusting the Company's Major Asset Restructuring Transaction Plan" deliberated and approved at the 16th Meeting of the Fourth Board of Directors, as follows:
1.01 Adjustment to "Performance Commitment and Compensation"